Joint diseases and matrix metalloproteinases: A role for MMP-13

Medicine & Life Sciences

• Joint Diseases 100%
• Matrix Metalloproteinases 87%
• Arthritis 47%
• Knockout Mice 33%
• Cartilage 31%
• Peptide Hydrolases 30%
• Matrix Metalloproteinase Inhibitors 21%
• Enzymes 19%
• Chondrocytes 18%
• Osteoarthritis 16%
• Rheumatoid Arthritis 15%
• Research Personnel 12%
• Clinical Trials 11%
• Pathology 11%
• Therapeutics 2%